GlassScriptPhysician profile
Matthew M Kruger
NPI 1265603781
$7,801.42
in general payments reported to CMS, 2019-2025
36 companies · $1,441 in 2025
The $1,441 reported for 2025 was more than what 84% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,070 · 2020: $401 · 2021: $761 · 2022: $997 · 2023: $1,230 · 2024: $1,902 · 2025: $1,441.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,338 · Entertainment: $111 · Education: $97.99 · Honoraria: $25.59.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,338.24 |
| Entertainment | $111.07 |
| Education | $97.99 |
| Honoraria | $25.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,840.70 | 2019-2025 | Clareon, Unity, Tryptyr |
| Bausch & Lomb Americas INC. | $552.29 | 2024 | Envista Mx60 Iol, Stellaris, Ic-8 Apthera Iol |
| Abbvie INC. | $517.75 | 2022-2025 | |
| Rxsight INC | $496.03 | 2021-2024 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Contact Lens |
| Sight Sciences, INC. | $374.78 | 2019-2023 | Tearcare System, Omni Surgical System |
| Aerie Pharmaceuticals, INC. | $374.18 | 2019-2021 | |
| Mallinckrodt Hospital Products INC. | $341.33 | 2022-2025 | Acthar |
| Allergan, INC. | $337.89 | 2019-2022 | |
| New World Medical,INC. | $335.24 | 2022-2023 | |
| Johnson & Johnson Surgical Vision, INC. | $306.78 | 2021-2024 | Tecnis Simplicity, Tecnis Iol |
| Sun Pharmaceutical Industries INC. | $245.83 | 2019-2025 | Cequa |
| Carl Zeiss Meditec USA, INC. | $190.35 | 2024 | Eq Workplace |
| Kala Pharmaceuticals, INC. | $173.33 | 2019-2021 | |
| Thea Pharma INC. | $158.31 | 2022-2025 | Iyuzeh |
| Microsurgical Technology, INC. | $154.06 | 2022 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $134.84 | 2019 | |
| Avedro INC. | $125.00 | 2019 | |
| Optos, INC. | $121.04 | 2020-2024 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Genzyme Corporation | $113.85 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $108.25 | 2024 | Reblozyl |
| Abb Con-Cise Optical Group LLC | $101.52 | 2021-2025 | Contact Lens, Spectacle Lenses |
| Tarsus Pharmaceuticals, INC. | $95.11 | 2024-2025 | Xdemvy |
| Novartis Pharmaceuticals Corporation | $84.59 | 2019-2023 | |
| Akorn Operating Company LLC | $80.15 | 2021 | |
| Dompe US, INC. | $72.18 | 2022-2025 | Oxervate |
| Akorn, INC. | $67.25 | 2020 | |
| Horizon Therapeutics Plc | $56.94 | 2023 | Tepezza |
| Nova Eye, INC. | $38.21 | 2024 | |
| Johnson & Johnson Vision Care, INC. | $37.89 | 2019-2022 | |
| Mallinckrodt Enterprises LLC | $34.18 | 2019 | |
| Oyster Point Pharma, INC. | $28.26 | 2025 | Tyrvaya, Ryzumvi |
| Coopervision INC. | $28.20 | 2019-2022 | |
| Biotissue Holdings INC. | $23.03 | 2022 | |
| Abbott Laboratories | $21.78 | 2021 | |
| Harrow Eye, LLC | $16.05 | 2024 | Vevye |
| Rayner Intraocular Lenses Limited | $14.25 | 2025 | Omidria |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Kruger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.